Martti Nurmi

2.6k total citations
56 papers, 2.0k citations indexed

About

Martti Nurmi is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Martti Nurmi has authored 56 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 20 papers in Surgery and 17 papers in Molecular Biology. Recurrent topics in Martti Nurmi's work include Bladder and Urothelial Cancer Treatments (16 papers), Prostate Cancer Treatment and Research (14 papers) and Urological Disorders and Treatments (11 papers). Martti Nurmi is often cited by papers focused on Bladder and Urothelial Cancer Treatments (16 papers), Prostate Cancer Treatment and Research (14 papers) and Urological Disorders and Treatments (11 papers). Martti Nurmi collaborates with scholars based in Finland, United States and Sweden. Martti Nurmi's co-authors include Marja T. Nevalainen, Matti Laato, Kalle Alanen, Eeva Salminen, Peter J. Boström, Paula Martikainen, Erkki Rintala, Teuvo L.J. Tammela, Päivi Hietanen and Harri Juusela and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Analytical Chemistry.

In The Last Decade

Martti Nurmi

56 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martti Nurmi Finland 23 859 649 471 440 383 56 2.0k
Isabel Heidegger Austria 26 1.2k 1.4× 829 1.3× 553 1.2× 489 1.1× 554 1.4× 123 2.4k
Werner de Riese United States 22 851 1.0× 720 1.1× 244 0.5× 432 1.0× 387 1.0× 89 1.7k
Akira Komiya Japan 29 1.4k 1.6× 943 1.5× 438 0.9× 300 0.7× 492 1.3× 99 2.4k
Shusuke Akamatsu Japan 21 884 1.0× 692 1.1× 279 0.6× 154 0.3× 573 1.5× 156 1.8k
Herbert F.M. Karthaus Netherlands 20 1.7k 1.9× 2.0k 3.0× 429 0.9× 551 1.3× 1.1k 2.8× 39 3.6k
Makoto Sumitomo Japan 28 794 0.9× 1.3k 1.9× 849 1.8× 348 0.8× 667 1.7× 133 2.5k
Yongmei Chen United States 26 1.5k 1.7× 757 1.2× 348 0.7× 208 0.5× 566 1.5× 96 2.4k
Renea A. Taylor Australia 30 1.1k 1.3× 950 1.5× 768 1.6× 183 0.4× 503 1.3× 95 2.5k
Andrew S. Goldstein United States 22 1.2k 1.4× 1.1k 1.7× 955 2.0× 229 0.5× 498 1.3× 57 2.5k
Μakoto Fujime Japan 18 314 0.4× 678 1.0× 284 0.6× 223 0.5× 145 0.4× 73 1.3k

Countries citing papers authored by Martti Nurmi

Since Specialization
Citations

This map shows the geographic impact of Martti Nurmi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martti Nurmi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martti Nurmi more than expected).

Fields of papers citing papers by Martti Nurmi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martti Nurmi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martti Nurmi. The network helps show where Martti Nurmi may publish in the future.

Co-authorship network of co-authors of Martti Nurmi

This figure shows the co-authorship network connecting the top 25 collaborators of Martti Nurmi. A scholar is included among the top collaborators of Martti Nurmi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martti Nurmi. Martti Nurmi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Boström, Peter J., Tuomas Mirtti, Bas van Rhijn, et al.. (2016). Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy. Bladder Cancer. 2(2). 263–272. 6 indexed citations
3.
Lilja, Hans, Angel M. Cronin, Otto Kauko, et al.. (2013). Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens. Clinical Biochemistry. 46(7-8). 670–674. 10 indexed citations
4.
Jambor, Ivan, Ronald Borra, Jukka Kemppainen, et al.. (2010). Functional Imaging of Localized Prostate Cancer Aggressiveness Using 11C-Acetate PET/CT and 1H-MR Spectroscopy. Journal of Nuclear Medicine. 51(11). 1676–1683. 43 indexed citations
5.
Dagvadorj, Ayush, Shyh‐Han Tan, Zhiyong Liao, et al.. (2010). N-terminal truncation of Stat5a/b circumvents PIAS3-mediated transcriptional inhibition of Stat5 in prostate cancer cells. The International Journal of Biochemistry & Cell Biology. 42(12). 2037–2046. 21 indexed citations
6.
Boström, Peter J., Jyrki Kössi, Matti Laato, & Martti Nurmi. (2008). Risk factors for mortality and morbidity related to radical cystectomy. British Journal of Urology. 103(2). 191–196. 108 indexed citations
7.
Kauko, Otto, Siina Junnila, Ville Väisänen, et al.. (2007). Quantitative real-time RT-PCR assay for PCA3. Clinical Biochemistry. 41(1-2). 103–108. 32 indexed citations
8.
Lilja, Hans, et al.. (2006). Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood. Clinical Biochemistry. 40(1-2). 111–118. 8 indexed citations
9.
Sutinen, Eija, Martti Nurmi, Anne Roivainen, et al.. (2004). Kinetics of [ 11 C]choline uptake in prostate cancer: a PET stydy. European Journal of Nuclear Medicine and Molecular Imaging. 31(3). 317–324. 147 indexed citations
10.
Ahonen, Tommi J., Jian‐Wu Xie, Matthew J. LeBaron, et al.. (2003). Inhibition of transcription factor Stat5 induces cell death of human prostate cancer cells.. Journal of Biological Chemistry. 278(40). 39259–39259. 6 indexed citations
11.
Pettersson, Kim, Jussi Nurmi, Kerttu Irjala, et al.. (2002). Simultaneous Quantification of Prostate-specific Antigen and Human Glandular Kallikrein 2 mRNA in Blood Samples from Patients with Prostate Cancer and Benign Disease. Clinical Chemistry. 48(8). 1265–1271. 10 indexed citations
12.
Raitanen, Mika, Timo Marttila, Martti Nurmi, et al.. (2001). HUMAN COMPLEMENT FACTOR H RELATED PROTEIN TEST FOR MONITORING BLADDER CANCER. The Journal of Urology. 165(2). 374–377. 35 indexed citations
13.
Boström, Peter J., Pekka Uotila, Pertti Rajala, et al.. (2001). Interferon-α inhibits cyclooxygenase-1 and stimulates cyclooxygenase-2 expression in bladder cancer cells in vitro. Urological Research. 29(1). 20–24. 16 indexed citations
14.
Valve, Eeva, et al.. (2001). Increased Expression of FGF-8 Isoforms and FGF Receptors in Human Premalignant Prostatic Intraepithelial Neoplasia Lesions and Prostate Cancer. Laboratory Investigation. 81(6). 815–826. 57 indexed citations
15.
Aaltonen, Vesa, Peter J. Boström, Karl‐Ove Söderström, et al.. (1999). Urinary Bladder Transitional Cell Carcinogenesis Is Associated with Down-Regulation of NF1 Tumor Suppressor Gene in Vivo and in Vitro. American Journal Of Pathology. 154(3). 755–765. 39 indexed citations
16.
Haarala, Mervi, Jari Jalava, Matti Laato, et al.. (1996). Absence of Bacterial DNA in the Bladder of Patients With Interstitial Cystitis. The Journal of Urology. 156(5). 1843–1845. 32 indexed citations
17.
Ekfors, T, et al.. (1992). Ultrastructure and Immunohistochemistry of a Fetal-type Leydig Cell Tumor. Ultrastructural Pathology. 16(6). 651–658. 2 indexed citations
18.
Nurmi, Martti, et al.. (1988). Reliability of CT in Preoperative Evaluation of Bladder Carcinoma. Scandinavian Journal of Urology and Nephrology. 22(2). 125–128. 13 indexed citations
19.
Ekfors, T & Martti Nurmi. (1988). Primary signet‐ring cell carcinoma of the ureter. Apmis. 96(1-6). 471–474. 6 indexed citations
20.
Nurmi, Martti, et al.. (1987). Renal Artery Embolization in the Palliative Treatment of Renal Adenocarcinoma. Scandinavian Journal of Urology and Nephrology. 21(2). 93–96. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isabel Heidegger Breakdown of academic impact, for papers by Werner de Riese Breakdown of academic impact, for papers by Akira Komiya Breakdown of academic impact, for papers by Shusuke Akamatsu Breakdown of academic impact, for papers by Herbert F.M. Karthaus Breakdown of academic impact, for papers by Makoto Sumitomo Breakdown of academic impact, for papers by Yongmei Chen Breakdown of academic impact, for papers by Renea A. Taylor Breakdown of academic impact, for papers by Andrew S. Goldstein Breakdown of academic impact, for papers by Μakoto Fujime
Rankless by CCL
2026